APA (7th ed.) Citation

Martin, N. T., Crupi, M. J. F., Taha, Z., Poutou, J., Whelan, J. T., Vallati, S., . . . Bell, J. C. (2023). Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy. Pharmaceuticals (14248247), 16(5), 709. https://doi.org/10.3390/ph16050709

Chicago Style (17th ed.) Citation

Martin, Nikolas T., et al. "Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy." Pharmaceuticals (14248247) 16, no. 5 (2023): 709. https://doi.org/10.3390/ph16050709.

MLA (9th ed.) Citation

Martin, Nikolas T., et al. "Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy." Pharmaceuticals (14248247), vol. 16, no. 5, 2023, p. 709, https://doi.org/10.3390/ph16050709.